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Abstrak: Setakat ini, mekanisme genetik yang lengkap tentang kemajuan adenoma 
kepada karsinoma dalam karsinoma usus besar masih belum diketahui. Demi 
memperoleh maklumat genetik tentang lintasan karsinogenesis ini, kami menggunakan 
kaedah pencarian gen yang diekspres secara berbeza dalam tumor karsinoma usus 
besar. Profil pengekspresan gen daripada kes karsinoma usus besar dikaji menggunakan 
sistem DNA Microarray. Kami melaporkan pengawalaturan tinggi dan rendah untuk 819 
dan 98 gen masing-masing dalam tumor relatif kepada kawalan normal berkenaan. Corak 
pengekspresan berbeza dalam 121 gen adalah kekal dalam semua tumor yang dikaji. 
Tiga puluh tiga daripada gen-gen ini adalah gen protein ribosom (RP). Perbandingan data 
dengan pangkalan data pengekspresan gen domain awam (Cancer Gene Expression 
Database, CGED) menunjukkan 47 gen pengekspresan berbeza adalah konsisten. Dua 
puluh dua daripada gen-gen ini adalah gen RP. Antara semua gen RP yang dikenal pasti 
dalam kajian ini, corak pengekspresan untuk enam gen adalah selaras dengan sorotan 
kajian. Pengekspresan tinggi gen RP L32 dilaporkan buat pertama kali dalam kajian ini 
dan telah disahkan melalui penganalisaan RT-PCR. Gen-gen yang tidak berkaitan dengan 
RP tetapi penting untuk dipertimbang adalah gen tumour susceptibility (TSG101) dan 20-
kDa myosin light chain (MLC-2).  Walaupun penganalisaan microarray kami berdasarkan 
saiz sampel kecil (n = 2), kajian awal ini mengenal pasti banyak gen yang dikaitkan 
dengan konteks pembentukan dan kemajuan karsinoma usus besar buat pertama kali. 
Maka, penemuan kami membekalkan maklumat baru untuk kejadian genetik dalam proses 
karsinoma usus besar.  
 
Abstract: Presently, the complete genetic mechanisms for the progression of adenoma to 
carcinoma for colorectal carcinoma (CRC) remain largely unclear. In order to obtain 
genetic information of this cancer pathway, we searched for differentially expressed genes 
in tumours of CRC. Gene expression profiles from CRC cases were assessed via the DNA 
microarray system. We report up-regulation and down-regulation of 819 and 98 genes 
respectively, in the tumours relative to their normal controls. The differential expression 
patterns of 121 genes were persistent in all tumours. Thirty three of these are ribosomal 
proteins (RPs) genes. Comparison of the 121 genes with a public domain gene expression 
database, the Cancer Gene Expression Database (CGEP), revealed 47 genes to be 
consistently differentially expressed in colorectal tumours. Among these, 22 are RP genes. 
Among all RP genes identified in this study the over-expression pattern for six of them is 
consistent with literature.  The up-regulation of RP L32 in CRC tumours was demonstrated 
for the first time in this study and it was also verified via reverse transcription-polymerase  
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chain reaction (RT-PCR) analysis. Non-RP genes worth noting are the tumour 
susceptibility gene (TSG101) and the 20-kDa myosin light chain (MLC-2). Albeit small 
sample size (n = 2 for microarray analysis), our preliminary studies revealed many genes 
that are brought into the context of CRC tumourigenesis for the first time, thus providing 
new clues to the genetic events during colorectal carcinogenesis.  
 






Colorectal carcinoma (CRC) is one of the human cancer models where the 
progressive histopathological stages correlate with gradual but sequential 
perturbation of specific genes. These basic and sequential events that correlate 
with the adenoma-carcinoma progression have been reviewed by Fodde et al. 
(2001). Generally, in the case of a type of inheritable CRC – the familial 
adenomatous polyposis (FAP), initiation of tumour formation and clonal evolution 
of tumourigenic cells can be triggered by germline inactivating mutations in the 
adenomatous polyposis coli (APC) gene. In the context of Wnt-signaling pathway, 
the improper function of mutant APC leads to the stabilization of β-catenin, and 
hence the formation of the β-catenin/TCF-LEF (T-cell factor-lymphoid enchancer 
factor) complex. This results in the ectopic activation of oncogenes, one of which 
is k-ras. This in turn leads to a proportion of precancerous colorectal cells 
becoming adenomatous polyps. Further genetic disruption specifically in the form 
of Loss of Heterozygosity (LOH) at chromosomes 18q and 17p involving 
SMAD2/SMAD4 and TP53 genes respectively, causes the malignant 
transformation of benign adenomas to invasive carcinoma of the colorectum. This 
basic sequence of genetic events in colorectal cancer evolution may also be true 
for sporadic CRC, as APC mutations have been verified in early stages of 
sporadic CRC tumours (Powell et al. 1992). Contrary to the phenomenon of APC-
initiated tumourigenesis, genetic defects (causing tumour progression) in the 
second familial forms of CRC, the Hereditary Nonpolyposis Colorectal Cancer 
(HNPCC), occur in the DNA mismatch repair (MMR) genes (Kinzler & Vogelstein 
1996). In the HNPCC cases, MMR deficiencies concomitantly cause adenomas 
to acquire higher rate of mutation relative to normal colorectal cells. The resultant 
accumulation of mutations in oncogenes and tumor suppressor genes will lead to 
malignant transformation of adenomas (Kinzler & Vogelstein 1996).  
The variety of genetic pathways that pertain to the adenoma-carcinoma 
sequence between FAP (and some sporadic CRC) and HNPCC reflects the 
complexities of the molecular mechanisms underlying tumor initiation to 
malignant progression of colorectal carcinoma. Presently, the understanding of 
these mechanisms remains basic if not partially elucidated. Of late, several 
groups have attempted to study the molecular events of colorectal carcinoma 
using approaches of gene expression analysis. These include the Serial Analysis 
of Gene Expression (SAGE) analysis (Zhang et al. 1997), the Affymetrix Human 
GeneChipTM (6500 and 6800) Set oligonucleotide arrays (Notterman et al. 2001), 
the 19,200-Element Complementary DNA microarray (Hedge et al. 2001), the 
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